PRJNA438478: RNAseq of wild type zebrafish germline
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
gata2a | dr11_v1_chr11_-_3865472_3865472 | 0.82 | 2.8e-05 | Click! |
gata1b | dr11_v1_chr8_-_7474997_7474997 | 0.78 | 1.2e-04 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr3_+_55105066 Show fit | 5.24 |
ENSDART00000110848
|
si:ch211-5k11.8 |
|
chr13_+_2908764 Show fit | 3.36 |
ENSDART00000162362
|
wu:fj16a03 |
|
chr3_+_55100045 Show fit | 3.13 |
ENSDART00000113098
|
hemoglobin, alpha adult 1 |
|
chr10_-_29236860 Show fit | 2.76 |
ENSDART00000111620
|
coiled-coil domain containing 83 |
|
chr23_-_23401305 Show fit | 2.69 |
ENSDART00000078936
|
hairy-related 9 |
|
chr7_+_35075847 Show fit | 2.59 |
ENSDART00000193469
ENSDART00000037346 |
chymotrypsinogen B1 |
|
chr23_+_7379728 Show fit | 2.58 |
ENSDART00000012194
|
GATA binding protein 5 |
|
chr16_-_24815091 Show fit | 2.50 |
ENSDART00000154269
ENSDART00000131025 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
|
chr2_+_33051730 Show fit | 2.44 |
ENSDART00000177902
ENSDART00000187903 |
ring finger protein 220a |
|
chr24_+_2843268 Show fit | 2.36 |
ENSDART00000170529
|
si:ch211-152c8.2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 9.8 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 8.5 | GO:0016567 | protein ubiquitination(GO:0016567) |
0.8 | 3.9 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 3.1 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.1 | 2.6 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.0 | 2.4 | GO:0071466 | cellular response to xenobiotic stimulus(GO:0071466) |
0.2 | 2.3 | GO:0046314 | phosphagen metabolic process(GO:0006599) phosphocreatine metabolic process(GO:0006603) phosphagen biosynthetic process(GO:0042396) phosphocreatine biosynthetic process(GO:0046314) |
0.0 | 2.0 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 1.8 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) |
0.5 | 1.6 | GO:0035971 | peptidyl-histidine dephosphorylation(GO:0035971) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 9.8 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.0 | 2.5 | GO:0043025 | neuronal cell body(GO:0043025) |
0.0 | 2.3 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.0 | 2.0 | GO:0005930 | axoneme(GO:0005930) |
0.0 | 1.6 | GO:0043204 | perikaryon(GO:0043204) |
0.3 | 1.5 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.0 | 1.5 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 1.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 1.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 1.3 | GO:0099569 | presynaptic cytoskeleton(GO:0099569) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 9.8 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.0 | 5.7 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.0 | 4.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 3.9 | GO:0042802 | identical protein binding(GO:0042802) |
0.3 | 2.5 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 2.5 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.2 | 2.3 | GO:0016775 | creatine kinase activity(GO:0004111) phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.1 | 2.1 | GO:0005518 | collagen binding(GO:0005518) |
0.5 | 2.0 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.1 | 2.0 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.3 | 2.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 2.0 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 1.7 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 1.2 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 1.0 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 3.9 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.4 | 2.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 2.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 2.5 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.2 | 2.0 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 1.5 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 1.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 1.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 1.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.7 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |